High cholesterol in lipid rafts reduces the sensitivity to EGFR‐TKI therapy in non‐small cell lung cancer
- 25 March 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (9) , 6722-6732
Abstract
Overcoming EGFR‐TKI resistant which has the initial enthusiasm over substantial clinical responses is a formidable challenge on nowadays. In this study, we showed that cholesterol level in lipid rafts in gefitinib resistant non‐small cell lung cancer (NSCLC) cell lines was remarkably higher than gefitinib sensitive cell line, and depletion of cholesterol increased gefitinib sensitivity. Furthermore, cholesterol‐depleted enhanced gefitinib inhibit phosphorylation of EGFR, Akt‐1, MEK1/2, and ERK1/2 and these were reversed in cholesterol add‐back experiments. Gefitinib resistant cell lines showed high affinity of gefitinib and EGFR when cholesterol was depleted. Therefore, targeting cholesterol combined with EGFR‐TKI is potentially a novel therapeutic strategy for gefitinib resistant treatment.Keywords
Funding Information
- Innovative Project of Postgraduate in Jiangsu Province (KYLX16_1201)
This publication has 39 references indexed in Scilit:
- New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical TrialsJournal of Clinical Oncology, 2013
- The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell GrowthPLOS ONE, 2012
- Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterificationClinical & Experimental Metastasis, 2011
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR InhibitorsScience Translational Medicine, 2011
- Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinibJournal of Cellular Physiology, 2010
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATPProceedings of the National Academy of Sciences, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancerJournal of Clinical Investigation, 2006
- Localization of Epidermal Growth Factor-stimulated Ras/Raf-1 Interaction to Caveolae MembraneJournal of Biological Chemistry, 1996
- Regulation of the mevalonate pathwayNature, 1990